Is diphenhydramine effective for treating allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Diphenhydramine Effective for Allergies?

Yes, diphenhydramine is highly effective for treating allergic symptoms including runny nose, sneezing, itchy/watery eyes, and itching of the nose or throat, but second-generation antihistamines like fexofenadine, desloratadine, or loratadine are strongly preferred due to diphenhydramine's significant sedation and cognitive impairment. 1, 2

FDA-Approved Indications and Efficacy

  • Diphenhydramine is FDA-approved to temporarily relieve symptoms due to hay fever or other respiratory allergies, including runny nose, sneezing, itchy/watery eyes, and itching of the nose or throat 1
  • The medication is a histamine H1-receptor antagonist with proven efficacy in treating allergic reactions including anaphylaxis, urticaria, and allergic rhinitis 3, 4
  • In a head-to-head trial, diphenhydramine 50 mg three times daily provided 77.6% reduction in nasal symptom scores compared to baseline (P < .001), significantly outperforming desloratadine which only achieved 21.0% reduction (P = .12) 5
  • Diphenhydramine demonstrated clinically superior improvements across all individual allergy symptoms, including the notoriously difficult-to-treat nasal congestion 5

Critical Safety Concerns That Override Efficacy

Despite its superior efficacy, diphenhydramine should NOT be first-line therapy for allergic rhinitis due to substantial impairment risks. 2

Cognitive and Performance Impairment

  • First-generation antihistamines like diphenhydramine cause significant sedation and impairment in school and driving performance 4
  • Young adults with seasonal allergic rhinitis treated with diphenhydramine 50 mg performed significantly worse on learning tests compared to those treated with non-sedating antihistamines (P < .001) 6
  • The impairment persists even after training periods, with examination performance remaining significantly worse in diphenhydramine-treated patients compared to controls (P < .001) 6
  • Expert consensus strongly recommends against using older agents like diphenhydramine because they produce sedation, impairment, and worsen sleep architecture 2

Sedation Rates

  • Somnolence occurred in 22.1% of patients taking diphenhydramine compared to only 4.5% with desloratadine and 3.4% with placebo 5
  • The sedative effects are increased when combined with alcohol or other CNS depressants such as benzodiazepines or opioid narcotics 7, 4

Additional Adverse Effects

  • Anticholinergic effects include hypotension, dizziness, blurred vision, dry mouth, epigastric discomfort, urinary retention, and wheezing 7, 4
  • Paradoxical increase in rage and agitation can occur, particularly in children and adolescents 4
  • Older adults face increased sensitivity and risk of side effects, including potential for delirium 4

Recommended Approach: Second-Generation Antihistamines First

Allergic rhinitis should be managed with relatively nonimpairing second-generation antihistamines (loratadine, desloratadine, cetirizine, or fexofenadine) as first-line therapy. 2

Onset of Action Comparison

  • While diphenhydramine has historically been chosen for acute allergic reactions due to perceived faster onset, research shows this advantage is marginal 8
  • In a randomized crossover study comparing oral fexofenadine 180 mg to oral and intramuscular diphenhydramine 50 mg, no significant differences were found in time to achieve 50% reduction in histamine-induced flares (P = .09) 8
  • Diphenhydramine tended to work more rapidly than fexofenadine, but differences were not statistically significant 8
  • Given the adverse effect profile of diphenhydramine with only marginal onset advantage, the risk-to-benefit ratio favors oral fexofenadine for acute urticarial or allergic reactions 8

When Diphenhydramine May Be Appropriate

Anaphylaxis (Second-Line Only)

  • In anaphylaxis management, diphenhydramine 1-2 mg/kg or 25-50 mg parenterally is recommended as second-line therapy to epinephrine 7, 4
  • H1 antihistamines should never be administered alone in the treatment of anaphylaxis 7
  • Combination of diphenhydramine and ranitidine (H2 blocker) is superior to diphenhydramine alone, but both have much slower onset than epinephrine 7

Lidocaine Allergy Alternative

  • For patients with true allergy to lidocaine, 1% diphenhydramine injection can serve as an alternative local anesthetic, though it has longer onset (5 minutes vs 1 minute for lidocaine) and limited efficacy 7

Procedural Sedation Adjunct

  • As an adjunct to meperidine and midazolam during colonoscopy, diphenhydramine 50 mg improved overall sedation scores (9.4 vs 9.04, P = .017) and reduced requirements for meperidine (89.7 vs 100 mg, P = .003) and midazolam (3.4 vs 4.0 mg, P = .001) 7

Common Pitfalls to Avoid

  • Never use diphenhydramine as first-line for routine allergic rhinitis when second-generation antihistamines are available and appropriate 2
  • Never rely on diphenhydramine alone for anaphylaxis—epinephrine is the only first-line treatment 7
  • Avoid in patients who need to drive, operate machinery, or perform cognitively demanding tasks due to significant impairment risk 2, 6
  • Exercise caution in elderly patients due to increased risk of anticholinergic effects and delirium 4
  • Monitor for paradoxical reactions in children and adolescents, which cannot be predicted unless previously documented 4

References

Research

First do no harm: managing antihistamine impairment in patients with allergic rhinitis.

The Journal of allergy and clinical immunology, 2003

Research

Diphenhydramine: A Review of Its Clinical Applications and Potential Adverse Effect Profile.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025

Guideline

Use of Diphenhydramine in Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2006

Research

Effects of semprex-D and diphenhydramine on learning in young adults with seasonal allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1996

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Time-dependent inhibition of histamine-induced cutaneous responses by oral and intramuscular diphenhydramine and oral fexofenadine.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.